Gene: PLEKHA4
Official Full Name: pleckstrin homology domain containing A4provided by HGNC
Gene Summary: This gene encodes a pleckstrin homology (PH) domain-containing protein. The PH domain is found near the N-terminus and contains a putative phosphatidylinositol 3, 4, 5-triphosphate-binding motif (PPBM). Elevated expression of this gene has been observed in some melanomas. Alternate splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, May 2017]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO15077 | PLEKHA4 Knockout cell line (HCT 116) | Human | PLEKHA4 | 1:2~1:4 | Negative | Online Inquiry |
KO15078 | PLEKHA4 Knockout cell line (HEK293) | Human | PLEKHA4 | 1:3~1:6 | Negative | Online Inquiry |
PLEKHA4 Gene Knockout Cell Lines are specifically engineered mammalian cell lines with targeted disruptions in the PLEKHA4 gene, a critical regulator involved in cellular signaling and membrane dynamics. This advanced cellular tool allows researchers to study the functional role of PLEKHA4 in various biological processes, including cell growth, differentiation, and apoptosis, by providing a platform to investigate phenotypic alterations resulting from gene knockout.
The primary mechanism behind these knockout cell lines is the use of CRISPR-Cas9 technology, which enables precise editing of the PLEKHA4 gene. This method results in the elimination of PLEKHA4 expression, facilitating the analysis of downstream cellular pathways and responses. Through gene silencing, researchers can observe the biochemical and phenotypic changes in cellular behavior, making it invaluable for dissecting complex signaling networks and their implications in diseases, such as cancer and metabolic disorders.
In research and clinical settings, PLEKHA4 Gene Knockout Cell Lines offer profound insights into the molecular underpinnings of cellular function and disease pathology. They are particularly important in functional genomics studies, therapeutic target identification, and drug discovery, allowing for high-throughput screening and validation of molecular targets.
What sets these knockout cell lines apart from alternative models is their high specificity and genetic fidelity. Compared to traditional knockdown methods, which can result in incomplete silencing and off-target effects, our knockout models provide a definitive loss-of-function scenario, leading to more reliable experimental outcomes.
For researchers and clinicians keen on advancing their understanding of gene function and pursuing innovative therapeutic strategies, the PLEKHA4 Gene Knockout Cell Lines represent a significant tool that can enhance the translational relevance of their work.
Our company is committed to excellence in biological product development, leveraging cutting-edge technologies to deliver high-quality tools for scientific inquiry. With a dedication to supporting groundbreaking research, we offer a range of innovative products designed to push the boundaries of what's possible in biology and medicine.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.